Integrin-dependent response to laminin-511 regulates breast tumor cell invasion and metastasis

Kusuma N., Denoyer D., Eble J.A., Redvers R.P., Parker B.S., Pelzer R. Anderson R.L., Pouliot N.International Journal of Cancer, 2011

Laminin-511 is a potent adhesive and migratory substrate for metastatic breast tumor cells in vitro and its expression correlates with tumor grade and metastatic potential in vivo. Here the authors compared the metastatic potential of 4T1 mammary carcinoma cells to that of 4T1 variants isolated by repeated chemotactic migration toward LM-511 in vitro (4T1LMF4) followed by serial injection into the mammary gland and recovery of spontaneous metastases from the bone (4T1BM2). Variant subpopulations exhibited a distinct morphology on LM-511 and increased expression of b1 and b4 integrins compared to parental 4T1 cells. Importantly, mice inoculated with 4T1LMF4 and 4T1BM2 variants showed a 2.5- to 4-fold increase in the incidence of spontaneous metastasis to bone compared to 4T1 tumor-bearing mice. Functionally, 4T1BM2 variants were more adherent and more invasive toward LM-511 than parental 4T1 cells. Treatment of 4T1BM2 cells with lebein-1, a dis-integrin with selectivity toward LM-type integrin receptors, potently inhibited their migration and invasion toward LM-511. Similarly, a3b1 integrin-dependent migration and invasion of human MDA-MB-231 breast carcinoma cells toward LM-511 were significantly inhibited by lebein-1. Taken together, these results provide strong evidence that LM-511 contributes to the metastasis of breast tumors and suggest that targeting integrin-LM- 511 interactions with lebein-1 or other inhibitors of LM-511 receptors may have therapeutic potential for patients with advanced breast cancer.